Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

GermanyBack to Germany

Clinical trials in Munich – page 44

1 191 clinical trials in Munich, Germany across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Munich at a glance
1 191
clinical trials
  • Research sites8
Type of trial
Recruitment status
Quick filters

1 191 trials in Munich

Open in trial search

Small intestine adenocarcinoma

Not yet recruiting

Randomized trial of irinotecan drug combination versus standard therapy as first-line treatment in patients with locally advanced or metastatic small bowel adenocarcinoma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Breast cancer

Not yet recruiting

Study of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Camizestrant
  • Sponsor:AstraZeneca AB

Cartilage injury

Not yet recruiting

Non‑inferiority study of autologous minced cartilage and autologous cultured chondrocytes in adults with large full‑thickness knee cartilage defects

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Sponsor:Medical Center - University Of Freiburg

Acne

Not yet recruiting

Safety and Efficacy Study of the Acne mRNA vaccine (mrt1800, mrt1801, mrt1802) in Adults 18‑45 Years with Moderate to Severe Acne

Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Sponsor:Sanofi Vaccines US Inc.

Follicular lymphoma

Not yet recruiting

Study of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:AstraZeneca AB

Adrenogenital syndrome

Not yet recruiting

Study of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Crinecerfont
  • Sponsor:Neurocrine Biosciences Inc.

Dementia Alzheimer's type

Not yet recruiting

Phase 2 Randomized Study of Mivelsiran in Adults with Early-Stage Down Syndrome-Associated Alzheimer’s Disease

Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:ALN-961583
  • Sponsor:Alnylam Pharmaceuticals Inc.

Lichen sclerosus

Not yet recruiting

A Phase 3 Study of Delgocitinib Cream to Evaluate Efficacy and Safety in Adult Women with Lichen Sclerosus

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Leo Pharma A/S

B precursor type acute leukaemia

Not yet recruiting

Phase II study of autologous enriched T‑cell therapy expressing CD19 and CD22 CARs in Philadelphia‑negative B‑precursor ALL patients with measurable residual disease

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Enriched T Cells Retrovirally Transduced To Express Two Chimeric Antigen Receptors Targeting Cd19 And Cd22
  • Sponsor:Goethe University Frankfurt

Cardiac amyloidosis

Not yet recruiting

Efficacy and safety of eplontersen sodium plus ALXN2220 in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Alxn2220
  • Sponsor:AstraZeneca AB

Study of Surovatamig and Human IgG4 Kappa Monoclonal Antibody Against CD3 and CD19 in Adults with Antibody-Mediated Kidney Disease

Not yet recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
  • Sponsor:AstraZeneca AB

Acute lymphocytic leukaemia

Not yet recruiting

Study of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Blinatumomab
  • Sponsor:Universitaetsklinikum Schleswig-Holstein AöR

Other cities in Germany

The busiest research cities in the country

All 516 cities in Germany

Clinical research in Munich

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on various cancer types, including metastatic prostate cancer, colorectal cancer, and bladder cancer. Novel therapeutic approaches combining immunotherapy with established treatments are being investigated.

  • Prostate Cancer Treatment Innovations
  • Colorectal Cancer Therapies
  • Early-Stage Bladder Cancer Management

Research aims to improve survival rates and treatment effectiveness through targeted therapies and immunological approaches.

02 Cardiovascular and Hematological Studies

Important research in heart disease and blood conditions, including studies on TTR amyloidosis and prevention of thrombotic events. Novel medications are being tested to improve patient outcomes.

  • Cardiac Amyloidosis Treatment
  • Thrombosis Prevention
  • Cardiovascular Disease Management

Focus on developing innovative treatments for complex cardiovascular conditions and preventing blood clots.

03 Neurology and Mental Health

Advanced research into neurological conditions, particularly focusing on Alzheimer's disease and autoimmune dementia. Studies aim to develop new therapeutic approaches and improve diagnostic tools.

  • Early-Stage Alzheimer's Treatment
  • Autoimmune Dementia Therapy
  • Cognitive Function Studies

Innovative approaches to treating and managing neurodegenerative conditions.

04 Immunology and Infectious Diseases

Critical research in HIV prevention and immune system modulation, including studies on transplant medicine and vaccine development for yellow fever.

  • HIV Pre-Exposure Prophylaxis
  • Transplant Immunology
  • Vaccine Development

Focus on preventing infectious diseases and improving transplant outcomes through immunological interventions.

Back to GermanyAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.